نتایج جستجو برای: protease inhibitor

تعداد نتایج: 245560  

Journal: :Antimicrobial agents and chemotherapy 2008
Matthew F McCown Sonal Rajyaguru Sophie Le Pogam Samir Ali Wen-Rong Jiang Hyunsoon Kang Julian Symons Nick Cammack Isabel Najera

Specific inhibitors of hepatitis C virus (HCV) replication that target the NS3/4A protease (e.g., VX-950) or the NS5B polymerase (e.g., R1479/R1626, PSI-6130/R7128, NM107/NM283, and HCV-796) have advanced into clinical development. Treatment of patients with VX-950 or HCV-796 rapidly selected for drug-resistant variants after a 14-day monotherapy treatment period. However, no viral resistance w...

Journal: :Indian Journal of Pharmaceutical Sciences 2022

To observe the efficacy of ezetimibe combined with simvastatin coronary heart disease patients and its effect on retinol binding protein 4, thioredoxin interaction visceral adipose tissue serine protease inhibitor. 120 admitted in our hospital from May 2019 to 2020 were divided into control group observation group. Changes serum inhibitor blood lipids recorded. Seattle angina scale group, 18 ef...

Journal: :The Journal of biological chemistry 2003
Michael D Oberst Cicely A Williams Robert B Dickson Michael D Johnson Chen-Yong Lin

The activation of matriptase requires proteolytic cleavage at a canonical activation motif that converts the enzyme from a one-chain zymogen to an active, two-chain protease. In this study, matriptase bearing a mutation in its catalytic triad was unable to undergo this activational cleavage, suggesting that the activating cleavage occurs via a transactivation mechanism where interaction between...

Journal: :Applied and environmental microbiology 1992
Y Shiga K Hasegawa A Tsuboi H Yamagata S Udaka

A novel proteinaceous protease inhibitor was isolated from the culture supernatant of Bacillus brevis HPD31. The protease inhibitor of B. brevis (designated BbrPI) was produced extracellularly in multiple forms having at least three different molecular weights. One of them, BbrPI-a, was purified to near homogeneity and only showed inhibitory activity toward serine proteases, such as trypsin, ch...

Journal: :Current opinion in HIV and AIDS 2016
Caitlin A Moran M Neale Weitzmann Ighovwerha Ofotokun

PURPOSE OF REVIEW HIV infection is an established risk factor for osteoporosis and bone fracture. Combination antiretroviral therapy (cART) increases bone resorption leading to an additional 2-6% bone mineral density (BMD) loss within the first 1-2 years of therapy. Although tenofovir disoproxil fumarate is often blamed for antiretroviral drug-associated bone loss, evidence abounds to suggest t...

Journal: :Antimicrobial agents and chemotherapy 2002
Jean Servais Christine Lambert Jean-Marc Plesséria Elodie Fontaine Isabelle Robert Vic Arendt Thérèse Staub Robert Hemmer François Schneider Jean-Claude Schmit

An observational study assessed the longitudinal use of a new line probe assay for the detection of protease mutations. Probe assays for detection of reverse transcriptase (Inno-LiPA HIV-1 RT; Innogenetics) and protease (prototype kit Inno-LiPA HIV Protease; Innogenetics) mutations gave results for 177 of 199 sequential samples collected over 2 years from 26 patients failing two nucleoside reve...

Journal: :Antioxidants & redox signaling 2011
Joan L Arolas Salvador Ventura

The correct balance between proteases and their natural protein inhibitors is of great importance in living systems. Protease inhibitors usually comprise small folds that are crosslinked by a high number of disulfide bonds, making them perfect models for the study of oxidative folding. To date, the oxidative folding of numerous protease inhibitors has been analyzed, revealing a great diversity ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید